ATG5 and neoplasm: For example, in the lung cancer models of Cre–activatable KrasG12D or BrafV600E, the conditional KO of ATG5 or ATG7 accelerated tumor initiation as mentioned above, which were, however, diverted to benign oncocytoma (26–28).